Skip to main content
Log in

Inclusion body myositis : clinical and histopathological features of 36 patients

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

Thirty-six patients (15 females, 21 males) with inclusion body myositis (IBM) were studied. The diagnosis was established according to clinical and histopathological criteria. Clinical features were insidious onset of slowly progressive muscle weakness and wasting with depressed or absent tendon reflexes especially in the lower limbs. The pattern of muscle weakness was variable. The majority of patients (58%) showed proximal and symmetrical weakness usually most prominent in the legs. Isolated distal (6%) and asymmetrical weakness (19%) was less frequently observed. Myalgia occurred in 42% of the patients. The age at onset of symptoms ranged from 20 to 73 years (mean 47 years). Serum creatine kinase levels were normal (11%) or mildly elevated (89%). Needle electromyography revealed myopathic features in about 80% of the patients, and results of nerve conduction studies were normal in most of the cases. The predominant histopathological findings were numerous muscle fibers with rimmed vacuoles (100% of the patients), groups of atrophic fibers (92%), and inflammatory infiltrates (89%). The inflammatory infiltrates were located predominantly at endomysial sites and were composed mainly of T8 cells. Electron microscopy showed characteristic intracytoplasmic filamentous inclusions in all 36 cases. Immunosuppressive treatment in 16 patients failed to prevent disease progression in all but one patient with an associated Sjögren's syndrome. It is concluded that the consistent combination of typical histopathological findings and characteristic clinical features offers a firm basis for the diagnosis of IBM. IBM should be suspected in any adult patient presenting with clinical signs of a chronic polymyositis unresponsive to immunosuppressive therapy. The etiology and pathogenesis of IBM remain to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abbreviations

IBM:

inclusion body myositis

CK:

creatine kinase

MHC:

major histocompatibility complex

References

  1. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL (1986) Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 36:937–941

    Google Scholar 

  2. Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T-cells. Ann Neurol 16:193–208

    Google Scholar 

  3. Argov Z, Yarom R (1984) “Rimmed vacuole myopathy” sparing the quadriceps. A unique disorder in Iranian Jews. J Neurol Sci 64:33–43

    Google Scholar 

  4. Askanas V, Serdaroglu P, Engel WK, Alvarez RB (1991) Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett 130:73–76

    Google Scholar 

  5. Askanas V, Serdaroglu P, Engel WK, Alvarez RB (1992) Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light microscopic distinction from polymyositis. Neurology 42:460–461

    Google Scholar 

  6. Calabrese LH, Mitsumoto H, Chou SM (1987) Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum 30:397–402

    Google Scholar 

  7. Carpenter S, Karpati G, Heller I, Eisen A (1978) Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 28:8–17

    Google Scholar 

  8. Chad D, Good P, Adelman L, Bradley WG, Mills J (1982) Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 39:186–188

    Google Scholar 

  9. Chou SM (1967) Myxovirus-like structures in a case of human chronic polymyositis. Science 158:1453–1455

    Google Scholar 

  10. Chou SM (1986) Inclusion body myositis. A chronic persistent mumps myositis? Hum Pathol 17:765–777

    Google Scholar 

  11. Cohen MR, Sulaiman AR, Garancis JC, Wortman RL (1989) Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum 32:734–740

    Google Scholar 

  12. Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Andermann E, Andermann F (1988) Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. Brain 111:1025–1037

    Google Scholar 

  13. Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 325:1487–1498

    Google Scholar 

  14. Danon MJ, Friedmann M (1989) Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy. Can J Neurol Sci 16:436–438

    Google Scholar 

  15. Danon MJ, Reyes MG, Perurena OH, Masdeu JC, Manaligod JR (1982) Inclusion body myositis. A corticosteroid-resistant inflammatory myopathy. Arch Neurol 39:760–764

    Google Scholar 

  16. Dubowitz V (1985) Muscle biopsy. A practical approach. Ballière Tindall, London

    Google Scholar 

  17. Eisen A, Berry K, Gibson G (1983) Inclusion body myositis (IBM):myopathy or neuropathy? Neurology 33:1109–1114

    Google Scholar 

  18. Engel AG, Arahata K (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 16:209–215

    Google Scholar 

  19. Engel AG, Arahata K (1986) Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 17:704–721

    Google Scholar 

  20. Figarella-Branger D, Pellisier JF, Bianco N, Devictor B, Toga M (1990) Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol 79:528–536

    Google Scholar 

  21. Fukuhara N, Kumamoto T, Tsubaki T (1980) Rimmed vacuoles. Acta Neuropathol (Berl) 51:229–235

    Google Scholar 

  22. Gutmann L, Govindan S, Riggs JE, Schochet SS (1985) Inclusion body myositis and Sjögren's syndrome. Arch Neurol 42:1021–1022

    Google Scholar 

  23. Herson D, Serratrice G, Tome FMS (1983) Deficit moteur très lentement progressif prédominant aux membres inférieurs chez un homme de 47 ans. Rev Neurol (Paris) 139:769–775

    Google Scholar 

  24. Hübner G, Pongratz D (1980) Inclusion body myositis: an example of diagnostic electron microscopy. Biol Cellulaire 39:283–286

    Google Scholar 

  25. Jerusalem F, Zierz S (1991) Muskelerkrankungen. Klinik-Therapie-Pathologie. Thieme, Stuttgart

    Google Scholar 

  26. Jerusalem F, Baumgartner G, Wyler R (1972) Virus-ähnliche Einschlüsse bei chronischen neuro-muskulären Prozessen. Elektronenmikroskopische Biopsiebefunde von 2 Fällen. Arch Psychiatr Nervenkr 215:148–166

    Google Scholar 

  27. Jimi T, Satoh Y, Takeda A, Shibuya S, Wakayama Y, Sugita K (1992) Strong immunoreactivity of cathepsin L at the site of rimmed vacuoles in diseased muscles. Brain 115:249–260

    Google Scholar 

  28. Joy JL, Oh SJ, Baysal AI (1990) Electrophysiological spectrum of inclusion body myositis. Muscle Nerve 13:949–951

    Google Scholar 

  29. Julien J, Vital CL, Vallat JM, Lagueny A, Sapina D (1982) Inclusion body myositis. Clinical, biological and ultrastructural study. J Neurol Sci 55:15–24

    Google Scholar 

  30. Kallajoki M, Hyypiä T, Halonen P, Örvell C, Rima B, Kalimo H (1991) Inclusion body myositis and paramyxoviruses. Hum Pathol 22:29–32

    Google Scholar 

  31. Karpati G, Pouliot Y, Carpenter S (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23:64–72

    Google Scholar 

  32. Ketelsen UP, Beckmann R, Zimmermann H, Sauer M (1977) Inclusion body myositis. A “slow-virus” infection of skeletal musculature? Klin Wochenschr 55:1063–1066

    Google Scholar 

  33. Lacy JR, Simon DB, Neville HE, Ringel SP (1982) Inclusion body myositis: electrodiagnostic and nerve biopsy findings. Neurology 32 [Suppl 2]:A202

    Google Scholar 

  34. Lane RJM, Fulthorpe JJ, Hudgson P (1985) Inclusion body myositis: a case with associated collagen vascular disease responding to treatment. J Neurol Neurosurg Psychiatr 48:270–273

    Google Scholar 

  35. Lazaro RP, Barron KD, Dentinger MP, Lava NS (1986) Inclusion body myositis: Case reports and a reappraisal of an underrecognized type of inflammatory myopathy. Mt Sinai J Med 53:137–144

    Google Scholar 

  36. Lindberg C, Oldfors A, Hedström A (1990) Inclusion body myositis: peripheral nerve involvement. Combined morphological and electrophysiological studies on peripheral nerves. J Neurol Sci 99:327–338

    Google Scholar 

  37. Lindberg C, Borg K, Edström L, Hedström A, Oldfors A (1991) Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison. J Neurol Sci 103:76–81

    Google Scholar 

  38. Lisson G, Pongratz D, Hübner G, Wallesch C (1980) Klinik and Morphologie der sog. “Einschlußkorpermyositis”. Fortschr Neurol Psychiatr 48:121–127

    Google Scholar 

  39. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ (1989) Inclusion body myositis. Observations in 40 patients. Brain 112:727–747

    Google Scholar 

  40. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S (1991) Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 48:519–522

    Google Scholar 

  41. Matsubara S, Tanabe H (1982) Hereditary distal myopathy with filamentous inclusions. Acta Neurol Scand 65:363–383

    Google Scholar 

  42. Mendell JR, Sahenk Z, Gales T, Paul L (1991) Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 48:1229–1234

    Google Scholar 

  43. Mhiri C, Gheradi R (1990) Inclusion body myositis in French patients. A clinical pathological evaluation. Neuropathol Appl Neurobiol 16:333–344

    Google Scholar 

  44. Mikol J (1986) Inclusion body myositis. In: Engel AG, Banker BQ (eds) Myology. McGraw Hill, New York, pp 1423–1438

    Google Scholar 

  45. Mikol J, Felten-Papaiconomou A, Ferchal F, Perol Y, Gautier B, Haguenau M, Pepin B (1982) Inclusion-body myositis: clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen. Ann Neurol 11:576–581

    Google Scholar 

  46. Neville HE, Baumbach LL, Ringel SP, Russo LS, Sujansky E, Garcia CA (1992) Familial inclusion body myositis: evidence for autosomal dominant inheritance. Neurology 42:897–902

    Google Scholar 

  47. Nishino H, Engel AG, Rima BK (1989) Inclusion body myositis: the mumps virus hypothesis. Ann Neurol 25:260–264

    Google Scholar 

  48. Nonaka I, Sunohara N, Ishiura S, Satoyoshi E (1981) Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 51:141–155

    Google Scholar 

  49. Nonaka I, Sunohara N, Satoyoshi E, Terasawa K, Yonemoto K (1985) Autosomal recessive distal muscular dystrophy: a comparative study with distal myopathy with rimmed vacuole formation. Ann Neurol 17:51–59

    Google Scholar 

  50. Rammohan KW, Wolinsky J, Omerza J, Gales T, Kissel J, Mendell J (1988) Mumps virus in IBM: studies implicating cross-reactivity accounting for antigen localization. Neurology 38 [Suppl 1]:151

    Google Scholar 

  51. Riggs JE, Schochet SS, Gutmann L, McComas CF, Rogers JS (1984) Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol 41:93–95

    Google Scholar 

  52. Riggs JE, Schochet SS, Gutmann L, Lerfald SC (1989) Childhood onset inclusion body myositis mimicking limbgirdle muscular dystrophy. J Child Neurol 4:283–285

    Google Scholar 

  53. Ringel SP, Kenny KE, Neville HE, Giorno R, Carry MR (1987) Spectrum of inclusion body myositis. Arch Neurol 44:1154–1157

    Google Scholar 

  54. Salama J, Tomé FMS, Lebon P, Marie L, Delaporte P, Fardeau M (1981) Myosite à inclusion. Étude clinique, morphologique et virologique concernant une nouvelle observation associeé à une sclérodermie généralisée et à un syndrome de Klinefelter. Rev Neurol (Paris) 136:863–878

    Google Scholar 

  55. Serratrice G, Pellissier JF, Pouget J, Figarella-Branger D (1989) Formes cliniques des myosites à inclusions: 12 cas. Rev Neurol (Paris) 145:781–788

    Google Scholar 

  56. Sunohara N, Nonaka I, Kamei N, Satoyoshi E (1989) Distal myopathy with rimmed vacuole formation. A follow up study. Brain 112:65–83

    Google Scholar 

  57. Tomé FMS, Fardeau M (1986) Ocular myopathies. In: Engel AG, Banker BQ (eds) Myology. McGraw Hill, New York, pp 1327–1347

    Google Scholar 

  58. omé FMS, Fardeau M, Lebon P, Chevally M (1980) Inclusion body myositis. Acta Neuropathol (Berl) [Suppl VII]: 287–291

  59. Verma A, Bradley WG, Adesina AM, Sofferman R, Pendlebury WW (1991) Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia. Muscle Nerve 14:470–473

    Google Scholar 

  60. Verma A, Bradley WG, Soule NW, Pendlebury WW, Kelly J, Adelman LS, Chou SM, Karpati G, Brenner JF (1992) Quantitative morphometric study of muscle in inclusion body myositis. J Neurol Sci 112:192–198

    Google Scholar 

  61. Walton J (1991) The idiopathic inflammatory myopathies and their treatment. J Neurol Neurosurg Psychiatr 54:285–287

    Google Scholar 

  62. Yood RA, Smith TW (1985) Inclusion body myositis and systemic lupus erythematosus. J Rheumatol 12:568–570

    Google Scholar 

  63. Yunis EJ, Samaha FJ (1971) Inclusion body myositis. Lab Invest 25:240–248

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beyenburg, S., Zierz, S. & Jerusalem, F. Inclusion body myositis : clinical and histopathological features of 36 patients. Clin Investig 71, 351–361 (1993). https://doi.org/10.1007/BF00186623

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00186623

Key words

Navigation